ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RARE Ultragenyx Pharmaceutical Inc

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 89.34M90.7M103.35M100.5M108.31M98.05M127.39M108.83M
Operating Income -141.59M-225.07M-145.63M-154.11M-147.96M-145.1M-122.05M-165.35M
Pre Tax Income -157.86M-238.82M-153.28M-163.48M-159.1M-159M-126.89M-170.23M
Net Income -158.16M-245.11M-151.83M-163.97M-159.83M-159.65M-123.19M-170.68M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -142.23M-226.17M-145.45M-153.8M-149.64M-145.8M-120.01M-166.95M
EBITDA -137.11M-220.37M-140.67M-148.87M-142.6M-137.91M-113.83M-156.5M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 133k2.61M51.5M103.71M271.03M351.41M363.33M434.25M
Operating Income -248.01M-328.94M-371.37M-424.17M-330.12M-381.74M-648.92M-569.21M
Pre Tax Income -245.84M-318.34M-197.1M-399.44M-185.36M-452.98M-701.73M-608.46M
Net Income -245.87M-302.14M-197.61M-402.73M-186.57M-454.03M-707.42M-606.64M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -5.962-6.841-3.885-6.963-2.792-6.547-10.078-7.388
EBIT -249.63M-322.41M-206.64M-424.96M-329.51M-383.42M-650.49M-569.55M
EBITDA -244.58M-323.12M-351.84M-415.63M-317.86M-368.51M-630.7M-543.2M